The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein*
暂无分享,去创建一个
[1] H Nakatani,et al. Test reactions for a stopped-flow apparatus. Reduction of 2,6-dichlorophenolindophenol and potassium ferricyanide by L-ascorbic acid. , 1978, Analytical biochemistry.
[2] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[3] S. Prusiner,et al. Separation and properties of cellular and scrapie prion proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. W. Bolen,et al. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. , 1988, Biochemistry.
[5] B. Caughey,et al. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.
[6] L. Hood,et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.
[7] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Khorasanizadeh,et al. Folding and stability of a tryptophan-containing mutant of ubiquitin. , 1993, Biochemistry.
[9] P. Roller,et al. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity , 1993, Protein science : a publication of the Protein Society.
[10] P. Lansbury,et al. Cell-free formation of protease-resistant prion protein , 1994, Nature.
[11] R J Fletterick,et al. Structural clues to prion replication. , 1994, Science.
[12] C. Weissmann. Molecular biology of transmissible spongiform encephalopathies , 1996, Progress in brain research.
[13] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[14] M. Oliveberg,et al. Transient aggregates in protein folding are easily mistaken for folding intermediates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] K Wüthrich,et al. NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.
[16] F E Cohen,et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.
[17] J. Kelly,et al. Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases. , 1997, Structure.
[18] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[19] K Wüthrich,et al. Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refolding , 1997, FEBS letters.
[20] H. Roder,et al. Kinetic role of early intermediates in protein folding. , 1997, Current opinion in structural biology.
[21] M. Oliveberg,et al. High-energy channeling in protein folding. , 1997, Biochemistry.
[22] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Bürkle,et al. Overexpression of Nonconvertible PrPcΔ114–121 in Scrapie-Infected Mouse Neuroblastoma Cells Leads to trans-Dominant Inhibition of Wild-Type PrPSc Accumulation , 1998, Journal of Virology.
[24] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[25] W. Surewicz,et al. Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.
[26] S. Radford,et al. Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. , 1999, Journal of molecular biology.
[27] S. Marqusee,et al. Confirmation of the hierarchical folding of RNase H: a protein engineering study , 1999, Nature Structural Biology.
[28] J. Collinge,et al. Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.
[29] R. Glockshuber,et al. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.
[30] W. Surewicz,et al. Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.
[31] R. Glockshuber,et al. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates , 1999, Nature Structural Biology.
[32] B. Caughey. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads? , 2000, Nature Medicine.
[33] J. Weissman,et al. Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.
[34] T. Sosnick,et al. Distinguishing between two-state and three-state models for ubiquitin folding. , 2000 .
[35] A. Fersht. A kinetically significant intermediate in the folding of barnase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Roberts,et al. Prions of yeast as heritable amyloidoses. , 2000, Journal of structural biology.
[37] K Wüthrich,et al. NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Takei,et al. Absence of stable intermediates on the folding pathway of barnase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Chesebro,et al. Transmissible spongiform encephalopathies and prion protein interconversions. , 2001, Advances in virus research.
[40] W. Surewicz,et al. On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .
[41] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[42] Suzette Apriola. Prion protein diversity and disease in the transmissible spongiform encephalopathies , 2001 .
[43] B. Chesebro,et al. Sulfated glycans and elevated temperature stimulate PrPSc‐dependent cell‐free formation of protease‐resistant prion protein , 2001, The EMBO journal.
[44] F. Cohen,et al. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. , 2002, Journal of molecular biology.
[45] W. Surewicz,et al. Disease-associated F198S Mutation Increases the Propensity of the Recombinant Prion Protein for Conformational Conversion to Scrapie-like Form* , 2002, The Journal of Biological Chemistry.
[46] T. Sosnick,et al. Fast and slow intermediate accumulation and the initial barrier mechanism in protein folding. , 2002, Journal of molecular biology.
[47] C. Dobson,et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.
[48] S. Prusiner,et al. Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? , 2002, Biochemistry.
[49] W. Surewicz,et al. Kinetic Intermediate in the Folding of Human Prion Protein* , 2002, The Journal of Biological Chemistry.
[50] Susan Lindquist,et al. Prions as protein-based genetic elements. , 2002, Annual review of microbiology.
[51] S. Ferreira,et al. Folding Intermediates of the Prion Protein Stabilized by Hydrostatic Pressure and Low Temperature* , 2003, Journal of Biological Chemistry.
[52] E. M. Jones,et al. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] T. Kiefhaber,et al. Evidence for sequential barriers and obligatory intermediates in apparent two-state protein folding. , 2003, Journal of molecular biology.
[54] A. Fersht,et al. The kinetic pathway of folding of barnase. , 2003, Journal of molecular biology.